Quarterly report pursuant to Section 13 or 15(d)

BUSINESS AND RECAPITALIZATION (Details Narrative)

v3.7.0.1
BUSINESS AND RECAPITALIZATION (Details Narrative)
6 Months Ended
Jun. 30, 2017
Jul. 28, 2016
State of Incorporation Nevada  
BioCorRx Pharmaceuticals, Inc [Member] | BioCorRx, Inc [Member]    
Equity issued ownership   78.10%
Officer [Member] | BioCorRx Pharmaceuticals, Inc [Member]    
Equity issued ownership   21.90%